Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)

Clinical trial NCT06150898 · RECRUITING

Trial details

NCT number: NCT06150898
Sponsor: Jules Bordet Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Early-stage Breast Cancer Estrogen-receptor-positive Breast Cancer

Start date: 2025-05-12
Primary completion: 2027-04-20
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.